| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 77 | 2024 | 4673 | 4.320 |
Why?
|
| Catheter Ablation | 66 | 2024 | 2758 | 3.920 |
Why?
|
| Tachycardia, Supraventricular | 21 | 2023 | 274 | 3.260 |
Why?
|
| Wolff-Parkinson-White Syndrome | 13 | 2023 | 116 | 3.170 |
Why?
|
| Heart Conduction System | 29 | 2021 | 1015 | 3.060 |
Why?
|
| Arrhythmias, Cardiac | 32 | 2023 | 2255 | 2.790 |
Why?
|
| Long QT Syndrome | 12 | 2017 | 466 | 2.640 |
Why?
|
| Electrocardiography | 51 | 2024 | 6415 | 2.500 |
Why?
|
| Defibrillators, Implantable | 34 | 2023 | 1499 | 2.370 |
Why?
|
| Death, Sudden, Cardiac | 18 | 2023 | 1572 | 2.130 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 16 | 2024 | 149 | 1.950 |
Why?
|
| Tachycardia, Ventricular | 21 | 2023 | 1303 | 1.800 |
Why?
|
| Fontan Procedure | 13 | 2018 | 791 | 1.750 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 19 | 2024 | 504 | 1.710 |
Why?
|
| Accessory Atrioventricular Bundle | 6 | 2021 | 58 | 1.700 |
Why?
|
| Body Surface Potential Mapping | 11 | 2024 | 228 | 1.440 |
Why?
|
| Neonatal Screening | 5 | 2015 | 595 | 1.290 |
Why?
|
| Tachycardia, Ectopic Atrial | 6 | 2011 | 65 | 1.270 |
Why?
|
| Cardiac Pacing, Artificial | 21 | 2014 | 866 | 1.220 |
Why?
|
| Heart Block | 10 | 2022 | 392 | 1.040 |
Why?
|
| Models, Cardiovascular | 11 | 2009 | 977 | 1.000 |
Why?
|
| Cardiac Electrophysiology | 5 | 2021 | 59 | 0.990 |
Why?
|
| Electric Countershock | 15 | 2023 | 537 | 0.990 |
Why?
|
| Tetralogy of Fallot | 6 | 2021 | 631 | 0.980 |
Why?
|
| Tachycardia | 11 | 2023 | 603 | 0.920 |
Why?
|
| Pacemaker, Artificial | 16 | 2022 | 815 | 0.830 |
Why?
|
| Pre-Excitation Syndromes | 2 | 2021 | 27 | 0.810 |
Why?
|
| Electrophysiology | 8 | 2022 | 1265 | 0.810 |
Why?
|
| Atrial Flutter | 8 | 2023 | 258 | 0.770 |
Why?
|
| Child | 111 | 2024 | 79799 | 0.740 |
Why?
|
| Atrial Fibrillation | 12 | 2023 | 5209 | 0.740 |
Why?
|
| Heart Atria | 14 | 2013 | 1346 | 0.720 |
Why?
|
| Heart Rate | 18 | 2020 | 4180 | 0.710 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2024 | 2128 | 0.680 |
Why?
|
| Cardiac Surgical Procedures | 14 | 2023 | 3620 | 0.670 |
Why?
|
| Bundle-Branch Block | 3 | 2018 | 281 | 0.640 |
Why?
|
| Finite Element Analysis | 3 | 2010 | 428 | 0.620 |
Why?
|
| Echocardiography | 13 | 2024 | 4981 | 0.610 |
Why?
|
| Child, Preschool | 71 | 2024 | 42056 | 0.590 |
Why?
|
| Ventricular Fibrillation | 5 | 2018 | 539 | 0.560 |
Why?
|
| Heart Ventricles | 7 | 2024 | 3812 | 0.530 |
Why?
|
| Adolescent | 92 | 2024 | 87809 | 0.530 |
Why?
|
| Tachycardia, Sinoatrial Nodal Reentry | 4 | 2004 | 8 | 0.520 |
Why?
|
| Radiography, Interventional | 3 | 2013 | 1112 | 0.500 |
Why?
|
| Electrodes, Implanted | 9 | 2010 | 833 | 0.490 |
Why?
|
| Ebstein Anomaly | 3 | 2023 | 101 | 0.490 |
Why?
|
| Vectorcardiography | 2 | 2005 | 48 | 0.480 |
Why?
|
| Cardiology | 6 | 2021 | 1723 | 0.480 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2013 | 72 | 0.450 |
Why?
|
| Isoproterenol | 1 | 2014 | 394 | 0.450 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2013 | 63 | 0.450 |
Why?
|
| Humans | 194 | 2024 | 760613 | 0.440 |
Why?
|
| Radiation Dosage | 2 | 2013 | 1957 | 0.440 |
Why?
|
| Thorax | 1 | 2016 | 553 | 0.440 |
Why?
|
| Sick Sinus Syndrome | 2 | 2012 | 45 | 0.430 |
Why?
|
| Electrodes | 4 | 2018 | 614 | 0.430 |
Why?
|
| Monitoring, Physiologic | 3 | 2018 | 1784 | 0.430 |
Why?
|
| Heart Septum | 5 | 2019 | 303 | 0.420 |
Why?
|
| Infant | 52 | 2024 | 36053 | 0.420 |
Why?
|
| International Cooperation | 2 | 2016 | 1433 | 0.420 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 307 | 0.420 |
Why?
|
| Electrocardiography, Ambulatory | 6 | 2020 | 578 | 0.410 |
Why?
|
| Fluoroscopy | 4 | 2013 | 946 | 0.410 |
Why?
|
| Tachycardia, Reciprocating | 1 | 2012 | 15 | 0.410 |
Why?
|
| Transposition of Great Vessels | 3 | 2023 | 590 | 0.400 |
Why?
|
| Ablation Techniques | 1 | 2014 | 248 | 0.390 |
Why?
|
| Therapy, Computer-Assisted | 3 | 2008 | 267 | 0.390 |
Why?
|
| Pediatrics | 4 | 2016 | 3586 | 0.380 |
Why?
|
| Computer Simulation | 11 | 2018 | 6218 | 0.380 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3865 | 0.370 |
Why?
|
| Treatment Outcome | 55 | 2023 | 64981 | 0.360 |
Why?
|
| Risk Assessment | 17 | 2021 | 24102 | 0.350 |
Why?
|
| Tachycardia, Ectopic Junctional | 5 | 2023 | 20 | 0.340 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2005 | 708 | 0.330 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 611 | 0.330 |
Why?
|
| Retrospective Studies | 58 | 2024 | 80345 | 0.320 |
Why?
|
| Cryosurgery | 3 | 2009 | 475 | 0.320 |
Why?
|
| Troponin T | 1 | 2013 | 774 | 0.310 |
Why?
|
| Brugada Syndrome | 1 | 2009 | 95 | 0.310 |
Why?
|
| Boston | 10 | 2018 | 9278 | 0.300 |
Why?
|
| Genetic Markers | 1 | 2014 | 2609 | 0.300 |
Why?
|
| Adrenergic Agonists | 1 | 2008 | 58 | 0.300 |
Why?
|
| Disease Management | 2 | 2016 | 2514 | 0.300 |
Why?
|
| Anti-Arrhythmia Agents | 10 | 2023 | 784 | 0.300 |
Why?
|
| Societies, Medical | 3 | 2016 | 3905 | 0.300 |
Why?
|
| Heart | 8 | 2022 | 4393 | 0.290 |
Why?
|
| Atrioventricular Node | 7 | 2016 | 180 | 0.290 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2013 | 1007 | 0.280 |
Why?
|
| Female | 101 | 2024 | 391246 | 0.280 |
Why?
|
| Atrioventricular Block | 2 | 2022 | 121 | 0.280 |
Why?
|
| Male | 97 | 2024 | 359718 | 0.280 |
Why?
|
| Radiation Protection | 1 | 2010 | 425 | 0.280 |
Why?
|
| Age Factors | 14 | 2018 | 18413 | 0.280 |
Why?
|
| Endosonography | 1 | 2010 | 607 | 0.280 |
Why?
|
| Adult | 75 | 2024 | 220007 | 0.260 |
Why?
|
| Prosthesis Implantation | 3 | 2010 | 594 | 0.260 |
Why?
|
| Heart Diseases | 7 | 2012 | 2809 | 0.260 |
Why?
|
| Postoperative Complications | 14 | 2023 | 15679 | 0.250 |
Why?
|
| Neural Conduction | 2 | 2004 | 441 | 0.240 |
Why?
|
| Registries | 6 | 2016 | 8458 | 0.240 |
Why?
|
| Epinephrine | 1 | 2008 | 791 | 0.230 |
Why?
|
| Follow-Up Studies | 29 | 2020 | 39262 | 0.230 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2567 | 0.230 |
Why?
|
| Young Adult | 28 | 2024 | 58748 | 0.230 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 1174 | 0.220 |
Why?
|
| Radiation Injuries | 1 | 2010 | 1183 | 0.210 |
Why?
|
| Intracranial Thrombosis | 1 | 2004 | 109 | 0.210 |
Why?
|
| Cardiac Resynchronization Therapy | 4 | 2018 | 553 | 0.210 |
Why?
|
| Models, Statistical | 4 | 2015 | 5075 | 0.210 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2022 | 60 | 0.210 |
Why?
|
| Intracranial Embolism | 1 | 2004 | 192 | 0.200 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2021 | 152 | 0.200 |
Why?
|
| Sensitivity and Specificity | 10 | 2014 | 14661 | 0.200 |
Why?
|
| United States Food and Drug Administration | 2 | 2022 | 1677 | 0.200 |
Why?
|
| Risk Factors | 28 | 2020 | 74333 | 0.200 |
Why?
|
| Infant, Newborn | 24 | 2020 | 26179 | 0.200 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1209 | 0.200 |
Why?
|
| Hypotension | 1 | 2008 | 883 | 0.200 |
Why?
|
| Punctures | 2 | 2013 | 368 | 0.190 |
Why?
|
| Myocardium | 3 | 2012 | 4700 | 0.190 |
Why?
|
| Forecasting | 5 | 2019 | 2931 | 0.190 |
Why?
|
| Prevalence | 12 | 2020 | 15686 | 0.190 |
Why?
|
| Prostheses and Implants | 5 | 2019 | 1273 | 0.180 |
Why?
|
| Thromboembolism | 3 | 2017 | 1016 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2016 | 3426 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2013 | 3531 | 0.180 |
Why?
|
| DNA | 1 | 2014 | 7233 | 0.180 |
Why?
|
| Sotalol | 1 | 2020 | 47 | 0.170 |
Why?
|
| Food Hypersensitivity | 1 | 2008 | 697 | 0.170 |
Why?
|
| Electronics | 4 | 2021 | 315 | 0.170 |
Why?
|
| Autonomic Nervous System | 4 | 2001 | 697 | 0.170 |
Why?
|
| Mass Screening | 2 | 2012 | 5422 | 0.170 |
Why?
|
| Perfusion | 1 | 2004 | 1376 | 0.160 |
Why?
|
| Endocardium | 2 | 1997 | 246 | 0.160 |
Why?
|
| American Heart Association | 4 | 2021 | 1081 | 0.160 |
Why?
|
| Quality Improvement | 2 | 2015 | 3835 | 0.160 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 3465 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2016 | 1259 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2024 | 854 | 0.160 |
Why?
|
| Respiration | 3 | 1997 | 1654 | 0.150 |
Why?
|
| Equipment Failure | 8 | 2014 | 577 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 6 | 2008 | 1489 | 0.150 |
Why?
|
| Time Factors | 14 | 2020 | 40139 | 0.150 |
Why?
|
| Survival Rate | 10 | 2016 | 12810 | 0.150 |
Why?
|
| User-Computer Interface | 1 | 2004 | 1403 | 0.150 |
Why?
|
| Recurrence | 12 | 2022 | 8483 | 0.140 |
Why?
|
| Blood Volume | 2 | 2002 | 550 | 0.140 |
Why?
|
| Incidence | 10 | 2020 | 21391 | 0.140 |
Why?
|
| Equipment Design | 9 | 2018 | 3520 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 5 | 2012 | 5508 | 0.140 |
Why?
|
| Device Approval | 1 | 2018 | 165 | 0.140 |
Why?
|
| Stroke Volume | 2 | 2024 | 5523 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 1186 | 0.140 |
Why?
|
| Blood Pressure | 7 | 2005 | 8525 | 0.140 |
Why?
|
| Baroreflex | 4 | 2002 | 148 | 0.140 |
Why?
|
| Aortic Coarctation | 1 | 2018 | 282 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2007 | 4046 | 0.130 |
Why?
|
| Sudden Infant Death | 2 | 2014 | 291 | 0.130 |
Why?
|
| Decision Making | 2 | 2014 | 3925 | 0.130 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 12159 | 0.130 |
Why?
|
| United States | 16 | 2022 | 72448 | 0.130 |
Why?
|
| Device Removal | 3 | 2022 | 635 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 4 | 2013 | 1501 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2017 | 345 | 0.130 |
Why?
|
| Central Venous Pressure | 2 | 2002 | 79 | 0.130 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 15286 | 0.130 |
Why?
|
| Arrhythmia, Sinus | 1 | 1995 | 48 | 0.130 |
Why?
|
| Canada | 3 | 2016 | 2126 | 0.130 |
Why?
|
| Consensus | 4 | 2021 | 3113 | 0.130 |
Why?
|
| Heart Bypass, Right | 1 | 2015 | 75 | 0.120 |
Why?
|
| Telemetry | 3 | 2020 | 199 | 0.120 |
Why?
|
| Norwood Procedures | 1 | 2016 | 192 | 0.120 |
Why?
|
| Psychometrics | 1 | 2004 | 3051 | 0.120 |
Why?
|
| Algorithms | 7 | 2018 | 13982 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2000 | 819 | 0.110 |
Why?
|
| Tendons | 1 | 2018 | 552 | 0.110 |
Why?
|
| Pediatric Assistants | 1 | 2013 | 8 | 0.110 |
Why?
|
| Logistic Models | 4 | 2014 | 13312 | 0.110 |
Why?
|
| Pericardium | 1 | 2017 | 675 | 0.110 |
Why?
|
| Hospital Charges | 1 | 2015 | 359 | 0.100 |
Why?
|
| Sheep | 2 | 2010 | 1441 | 0.100 |
Why?
|
| Vena Cava, Superior | 1 | 1993 | 197 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2018 | 976 | 0.100 |
Why?
|
| Collateral Circulation | 1 | 1993 | 292 | 0.100 |
Why?
|
| False Positive Reactions | 1 | 2014 | 956 | 0.100 |
Why?
|
| Reproducibility of Results | 7 | 2018 | 20080 | 0.100 |
Why?
|
| Middle Aged | 31 | 2022 | 220359 | 0.100 |
Why?
|
| Reflex | 1 | 1994 | 376 | 0.100 |
Why?
|
| Swine | 8 | 2007 | 5899 | 0.100 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2012 | 138 | 0.100 |
Why?
|
| Feasibility Studies | 7 | 2017 | 5201 | 0.100 |
Why?
|
| Differential Threshold | 2 | 2012 | 80 | 0.100 |
Why?
|
| Sports | 1 | 2017 | 700 | 0.090 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 730 | 0.090 |
Why?
|
| Prospective Studies | 10 | 2015 | 54306 | 0.090 |
Why?
|
| Syncope | 2 | 2019 | 428 | 0.090 |
Why?
|
| Survival Analysis | 7 | 2009 | 10185 | 0.090 |
Why?
|
| Body Size | 3 | 2010 | 462 | 0.090 |
Why?
|
| Heart Septal Defects | 1 | 1992 | 191 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2016 | 805 | 0.090 |
Why?
|
| Spirometry | 1 | 2014 | 924 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 2014 | 368 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2013 | 491 | 0.090 |
Why?
|
| Amiodarone | 2 | 2005 | 218 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2016 | 1139 | 0.090 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 848 | 0.090 |
Why?
|
| Autopsy | 1 | 2013 | 1007 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2010 | 251 | 0.090 |
Why?
|
| Mutation | 1 | 2014 | 29957 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2557 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1548 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2013 | 1832 | 0.080 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2004 | 613 | 0.080 |
Why?
|
| Regression Analysis | 4 | 2010 | 6359 | 0.080 |
Why?
|
| Models, Anatomic | 2 | 2010 | 682 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 2108 | 0.080 |
Why?
|
| Biomedical Technology | 1 | 2010 | 211 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2417 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 2011 | 360 | 0.080 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2005 | 461 | 0.080 |
Why?
|
| Catheters, Indwelling | 2 | 2003 | 428 | 0.070 |
Why?
|
| Cold Temperature | 2 | 2005 | 780 | 0.070 |
Why?
|
| Thrombosis | 2 | 2020 | 3051 | 0.070 |
Why?
|
| Surgical Instruments | 2 | 2007 | 385 | 0.070 |
Why?
|
| Sinoatrial Node | 2 | 2001 | 99 | 0.070 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 866 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2014 | 1207 | 0.070 |
Why?
|
| Atrial Appendage | 1 | 2010 | 292 | 0.070 |
Why?
|
| Benchmarking | 1 | 2013 | 1044 | 0.070 |
Why?
|
| Exercise Test | 1 | 2014 | 2128 | 0.070 |
Why?
|
| Electromagnetic Fields | 1 | 2008 | 296 | 0.070 |
Why?
|
| Coronary Vessels | 3 | 2006 | 3112 | 0.070 |
Why?
|
| Computers, Handheld | 1 | 2008 | 210 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1415 | 0.070 |
Why?
|
| Pedigree | 1 | 2013 | 4578 | 0.060 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1985 | 115 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2012 | 3701 | 0.060 |
Why?
|
| Survivors | 1 | 2016 | 2375 | 0.060 |
Why?
|
| Cor Triatriatum | 1 | 2005 | 14 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2006 | 195 | 0.060 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2012 | 1311 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 1993 | 1398 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2012 | 1723 | 0.060 |
Why?
|
| Colony-Forming Units Assay | 1 | 1985 | 351 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 8950 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2010 | 18137 | 0.060 |
Why?
|
| Comorbidity | 4 | 2014 | 10553 | 0.060 |
Why?
|
| Control Groups | 1 | 2005 | 104 | 0.060 |
Why?
|
| Warfarin | 1 | 2013 | 1518 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 1993 | 1921 | 0.060 |
Why?
|
| Tricuspid Atresia | 1 | 2004 | 37 | 0.060 |
Why?
|
| Reference Values | 3 | 2024 | 4925 | 0.060 |
Why?
|
| Propafenone | 1 | 2023 | 27 | 0.060 |
Why?
|
| Therapeutic Irrigation | 1 | 2005 | 292 | 0.060 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2007 | 355 | 0.060 |
Why?
|
| Flecainide | 1 | 2023 | 41 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2002 | 6238 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2014 | 2985 | 0.050 |
Why?
|
| Case-Control Studies | 6 | 2024 | 22052 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6544 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2008 | 2061 | 0.050 |
Why?
|
| Cicatrix | 2 | 2001 | 782 | 0.050 |
Why?
|
| Dogs | 2 | 2005 | 3841 | 0.050 |
Why?
|
| Animals | 15 | 2016 | 167960 | 0.050 |
Why?
|
| Video-Assisted Surgery | 1 | 2003 | 51 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8552 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2008 | 734 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 822 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 1095 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2014 | 9716 | 0.050 |
Why?
|
| Atropine | 3 | 2000 | 245 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2003 | 408 | 0.050 |
Why?
|
| Aspirin | 1 | 2013 | 3364 | 0.050 |
Why?
|
| Diagnostic Imaging | 3 | 2021 | 3527 | 0.050 |
Why?
|
| Observer Variation | 2 | 2004 | 2601 | 0.050 |
Why?
|
| Atrial Function | 1 | 2001 | 99 | 0.050 |
Why?
|
| Anaphylaxis | 1 | 2008 | 755 | 0.040 |
Why?
|
| Action Potentials | 2 | 2020 | 1816 | 0.040 |
Why?
|
| Steroids | 1 | 2005 | 928 | 0.040 |
Why?
|
| Catheterization | 1 | 2005 | 1432 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 404 | 0.040 |
Why?
|
| Propranolol | 3 | 2000 | 489 | 0.040 |
Why?
|
| Postoperative Period | 3 | 1994 | 1818 | 0.040 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 2852 | 0.040 |
Why?
|
| Adenosine | 2 | 2013 | 834 | 0.040 |
Why?
|
| Hemodynamics | 5 | 2009 | 4173 | 0.040 |
Why?
|
| Organ Size | 1 | 2024 | 2254 | 0.040 |
Why?
|
| Tricuspid Valve | 2 | 2004 | 409 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1898 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 1214 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 615 | 0.040 |
Why?
|
| Age of Onset | 2 | 2016 | 3302 | 0.040 |
Why?
|
| Acute Disease | 1 | 2009 | 7268 | 0.040 |
Why?
|
| Software | 3 | 2008 | 4419 | 0.040 |
Why?
|
| Lung Volume Measurements | 2 | 2002 | 376 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2006 | 1181 | 0.040 |
Why?
|
| Exercise | 1 | 2014 | 5787 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 1046 | 0.040 |
Why?
|
| Radiography | 2 | 2009 | 6965 | 0.040 |
Why?
|
| Europe | 2 | 2014 | 3441 | 0.040 |
Why?
|
| Atrial Function, Right | 1 | 1997 | 32 | 0.040 |
Why?
|
| Length of Stay | 2 | 2020 | 6476 | 0.040 |
Why?
|
| Ecchymosis | 1 | 1997 | 32 | 0.040 |
Why?
|
| Off-Label Use | 1 | 2018 | 184 | 0.030 |
Why?
|
| Patients | 1 | 2023 | 906 | 0.030 |
Why?
|
| Seasons | 1 | 2002 | 1522 | 0.030 |
Why?
|
| Embolism, Air | 1 | 1997 | 110 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2013 | 5961 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2018 | 306 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 680 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2006 | 1870 | 0.030 |
Why?
|
| Pressoreceptors | 1 | 1996 | 100 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2017 | 2235 | 0.030 |
Why?
|
| Bradycardia | 1 | 1997 | 299 | 0.030 |
Why?
|
| Robotics | 1 | 2003 | 874 | 0.030 |
Why?
|
| Linear Models | 2 | 2018 | 5877 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12968 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 15840 | 0.030 |
Why?
|
| Heart Arrest, Induced | 1 | 1996 | 357 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2003 | 1758 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2018 | 788 | 0.030 |
Why?
|
| Proportional Hazards Models | 4 | 2014 | 12531 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1999 | 1735 | 0.030 |
Why?
|
| Reaction Time | 1 | 2000 | 2075 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2020 | 1479 | 0.030 |
Why?
|
| Massachusetts | 2 | 2017 | 8803 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2013 | 41337 | 0.030 |
Why?
|
| Photoplethysmography | 1 | 1994 | 60 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2005 | 12427 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 1994 | 439 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 3340 | 0.030 |
Why?
|
| Posture | 2 | 1997 | 953 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 1997 | 610 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.030 |
Why?
|
| Metals | 2 | 2007 | 736 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2012 | 142 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17790 | 0.020 |
Why?
|
| Rhabdomyoma | 1 | 2011 | 54 | 0.020 |
Why?
|
| Aortography | 1 | 1993 | 419 | 0.020 |
Why?
|
| Feedback | 1 | 1995 | 791 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4924 | 0.020 |
Why?
|
| Myxoma | 1 | 2011 | 114 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 2570 | 0.020 |
Why?
|
| Bundle of His | 1 | 2010 | 89 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1399 | 0.020 |
Why?
|
| Lung | 2 | 2002 | 9994 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10826 | 0.020 |
Why?
|
| Temperature | 1 | 1997 | 2221 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1992 | 218 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 1993 | 457 | 0.020 |
Why?
|
| Fibroma | 1 | 2011 | 190 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 461 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1993 | 983 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2015 | 14494 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 694 | 0.020 |
Why?
|
| Plasma Substitutes | 1 | 1989 | 57 | 0.020 |
Why?
|
| Starch | 1 | 1989 | 80 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 632 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2014 | 830 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 1004 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 298 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2023 | 3322 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1994 | 708 | 0.020 |
Why?
|
| Hospitalization | 2 | 2018 | 10789 | 0.020 |
Why?
|
| Child Welfare | 2 | 2002 | 516 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2129 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1993 | 745 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Heart Arrest | 1 | 1997 | 1506 | 0.020 |
Why?
|
| Albumins | 1 | 1989 | 577 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2011 | 911 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 25941 | 0.020 |
Why?
|
| Pharmacokinetics | 1 | 2005 | 86 | 0.020 |
Why?
|
| Wound Healing | 1 | 1997 | 2788 | 0.020 |
Why?
|
| Aorta | 1 | 1993 | 2039 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 22020 | 0.020 |
Why?
|
| Phlebography | 1 | 2006 | 325 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 2042 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3802 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2014 | 2255 | 0.020 |
Why?
|
| Acoustics | 1 | 2006 | 242 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 1154 | 0.010 |
Why?
|
| Connexins | 1 | 2006 | 351 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 697 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2006 | 472 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1985 | 641 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 245 | 0.010 |
Why?
|
| Prognosis | 4 | 2007 | 29661 | 0.010 |
Why?
|
| Heart Failure | 1 | 2007 | 11848 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 1649 | 0.010 |
Why?
|
| Computer Systems | 1 | 2004 | 470 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20509 | 0.010 |
Why?
|
| Patient Selection | 1 | 2014 | 4279 | 0.010 |
Why?
|
| Thoracoscopy | 1 | 2003 | 176 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2017 | 4897 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4563 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8623 | 0.010 |
Why?
|
| Stroke | 1 | 2004 | 9952 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 2001 | 75 | 0.010 |
Why?
|
| Veins | 1 | 2005 | 765 | 0.010 |
Why?
|
| Random Allocation | 2 | 2000 | 2394 | 0.010 |
Why?
|
| Carbachol | 1 | 2001 | 223 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3224 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2010 | 1996 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 2475 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2505 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2001 | 204 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2004 | 790 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5418 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2004 | 1096 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 1296 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 1490 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8556 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1653 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2007 | 2512 | 0.010 |
Why?
|
| North America | 1 | 2002 | 1284 | 0.010 |
Why?
|
| Databases, Factual | 2 | 2007 | 8022 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 699 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13505 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2001 | 546 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2001 | 353 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 2893 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 2647 | 0.010 |
Why?
|
| Procainamide | 1 | 1997 | 56 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 1985 | 1347 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7475 | 0.010 |
Why?
|
| Cause of Death | 1 | 2007 | 3725 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 5397 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6065 | 0.010 |
Why?
|
| Neoplasms | 1 | 1985 | 22075 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 1997 | 354 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2418 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2004 | 1486 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1996 | 273 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1996 | 293 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1628 | 0.010 |
Why?
|
| Research | 1 | 2003 | 1974 | 0.010 |
Why?
|
| Hydrops Fetalis | 1 | 1994 | 109 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 1385 | 0.010 |
Why?
|
| Aged | 5 | 2011 | 169143 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 3524 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11070 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1997 | 758 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2003 | 8055 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1997 | 1440 | 0.010 |
Why?
|
| Reoperation | 1 | 2001 | 4289 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 23709 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2000 | 2001 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11481 | 0.000 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 6659 | 0.000 |
Why?
|
| Water-Electrolyte Balance | 1 | 1989 | 325 | 0.000 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1994 | 1745 | 0.000 |
Why?
|
| Models, Biological | 1 | 2002 | 9468 | 0.000 |
Why?
|
| Neural Pathways | 1 | 1996 | 3040 | 0.000 |
Why?
|
| Mice | 2 | 2001 | 81209 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36286 | 0.000 |
Why?
|
| Phenotype | 1 | 2000 | 16548 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1985 | 13627 | 0.000 |
Why?
|
| Pregnancy | 1 | 1994 | 29746 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 58980 | 0.000 |
Why?
|